ArticleImmunology2014

Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.

Yan-Hua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.